nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstract #54: A Comparative Study of Ovarian Cancer Family History by Germline Genetic Testing Results
|
Shin, Rebecca |
|
|
57 |
S1 |
p. |
artikel |
2 |
Abstract #25: An Alternative to Excision: Use of Trichloroacetic Acid for Management of High Grade Cervical Dysplasia in Young Women
|
Batra, Sadhvi |
|
|
57 |
S1 |
p. |
artikel |
3 |
Abstract #28: A Needs Assessment of Surgical Learning Gaps in Gynecologic Oncology Fellows at a Single Institution
|
Lee, Yeon Woo |
|
|
57 |
S1 |
p. |
artikel |
4 |
Abstract #4: Assessing the quality of information on HPV and cervical cancer on TikTok
|
Alatorre, Andrea |
|
|
57 |
S1 |
p. |
artikel |
5 |
Abstract #9: Assessment of early-death in gynecologic malignancy among the Commission-on-Cancer facilities
|
Vallejo, Andrew |
|
|
57 |
S1 |
p. |
artikel |
6 |
Abstract #29: Association of Time to Surgery and Rates of Endometrial Cancer in Patients with Endometrial Intraepithelial Neoplasia
|
Kim, Justin |
|
|
57 |
S1 |
p. |
artikel |
7 |
Abstract #21: AXL inhibition improves the therapeutic efficacy of trastuzumab in uterine serous cancers
|
Walia, Anjali |
|
|
57 |
S1 |
p. |
artikel |
8 |
Abstract #41: Cancer care navigation, access to care, and adherence to guideline-based cervical cancer treatment across the 2nd largest US public healthcare system
|
Smick, Alexandra |
|
|
57 |
S1 |
p. |
artikel |
9 |
Abstract #2: CCL23 reduces expression of CXCL10 in the Ovarian Cancer Tumor Microenvironment as a novel Mechanism of Immuno-Suppression
|
Lang, Susan |
|
|
57 |
S1 |
p. |
artikel |
10 |
Abstract #64: Characterization and Length of Hospice Admission in Patients with Recurrent Cervical Cancer: A Retrospective Chart Review
|
Spencer, Nicole MP. |
|
|
57 |
S1 |
p. |
artikel |
11 |
Abstract #62: Characterization of Patients with Recurrent and Persistent Cervical Cancer after Chemoradiation Therapy: A Retrospective Chart Review
|
Quinto, Lauren |
|
|
57 |
S1 |
p. |
artikel |
12 |
Abstract #32: Clinical characteristics of patients with cervical cancer undergoing fertility-sparing surgery with cervical excision and lymph node evaluation
|
Zhang, Ashley |
|
|
57 |
S1 |
p. |
artikel |
13 |
Abstract #35: Clinical outcomes in non-English-speaking women undergoing cervical cancer treatment
|
Potter, Laura A. |
|
|
57 |
S1 |
p. |
artikel |
14 |
Abstract #7: Consideration of PARPi therapy in patients with uterine leiomyosarcoma harboring homologous recombination deficiency repair mutations
|
Wilson, Elise M. |
|
|
57 |
S1 |
p. |
artikel |
15 |
Abstract #24: Death with Dignity: Unveiling the Demographics of Medical Aid in Dying (MAID)
|
Blemur, Danielle |
|
|
57 |
S1 |
p. |
artikel |
16 |
Abstract #8: Differences in physical and emotional distress amongst patients undergoing neoadjuvant chemotherapy versus surgery for advanced ovarian cancer: patient-reported outcomes at diagnosis
|
Mokshagundam, Shilpa |
|
|
57 |
S1 |
p. |
artikel |
17 |
Abstract #20: Does timing matter? Association between time to chemotherapy and survival in ovarian cancer patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
|
Iugai, Sergei |
|
|
57 |
S1 |
p. |
artikel |
18 |
Abstract #46: Establishing a platform for investigating poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor sensitivity in PARP1 knockout cells
|
Nguy, Lindsey K. |
|
|
57 |
S1 |
p. |
artikel |
19 |
Abstract #12: Evaluating Caregiver Distress: Caring for Those Who Care for Our Patients
|
Haydamous, Joe |
|
|
57 |
S1 |
p. |
artikel |
20 |
Abstract #26: Exploring Sexual Distress and Surgical Decision-Making in Riskreducing Gynecologic Surgery
|
Othieno, Alisha A. |
|
|
57 |
S1 |
p. |
artikel |
21 |
Abstract #5: Factors associated with fertility sparing management and pregnancy in gynecologic precancer and cancer
|
Lowry, Christina |
|
|
57 |
S1 |
p. |
artikel |
22 |
Abstract #15: Fragmentation of care is associated with lower rates of receiving guideline concordant treatment in locally advanced cervical cancer
|
Mvemba, Audrey |
|
|
57 |
S1 |
p. |
artikel |
23 |
Abstract #11: Granulosa Cell Tumor: Impact of Surgical Route and Tumor Rupture on Recurrence
|
Dwyer, Erin |
|
|
57 |
S1 |
p. |
artikel |
24 |
Abstract #22: Impact of somatic TP53 mutation type on benefit from bevacizumab in patients with ovarian cancer, a secondary analysis of NRG/GOG-0218
|
Thiel, Kristina W. |
|
|
57 |
S1 |
p. |
artikel |
25 |
Abstract #58: Implementation of a Cancer Care Navigation Program in Gynecologic Oncology patients within Safety-net Hospitals
|
Cruz, Daisy |
|
|
57 |
S1 |
p. |
artikel |
26 |
Abstract #30: Incorporation of immunotherapy or biological targeted therapy in primary anti-cancer treatment in gynecologic malignancy
|
Lee, Matthew W. |
|
|
57 |
S1 |
p. |
artikel |
27 |
Abstract #3: Increasing Proportion of Adolescent and Young Adult (AYA) Patients Among Gynecologic Malignancies
|
Pino, Christian |
|
|
57 |
S1 |
p. |
artikel |
28 |
Abstract #52: Influence of genetic risk awareness on high grade serous fallopian tube carcinoma diagnoses
|
Walsh, Christine |
|
|
57 |
S1 |
p. |
artikel |
29 |
Abstract #38: In vitro characterization of patient-derived samples demonstrates the heterogeneity of high grade serous ovarian cancer
|
Ritchie, Julia |
|
|
57 |
S1 |
p. |
artikel |
30 |
Abstract #44: In vitro low passage patient-derived cells demonstrate lack of faithfulness to original sample
|
Ritchie, Julia |
|
|
57 |
S1 |
p. |
artikel |
31 |
Abstract #55: Lack of association of routine depression screening results with patient reported needs assessment
|
Smick, Alexandra |
|
|
57 |
S1 |
p. |
artikel |
32 |
Abstract #36: Let's talk about sex: Sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer survivors
|
Zuniga, Luis Felipe Falla |
|
|
57 |
S1 |
p. |
artikel |
33 |
Abstract #1: Liquid Biopsy Detection of Structural Variant Breakpoints to Monitor Ovarian Cancer Clonal Evolution
|
Li, Jian |
|
|
57 |
S1 |
p. |
artikel |
34 |
Abstract #61: Long-term survival outcomes of robotic-assisted versus traditional laparoscopy for the treatment of stage I endometrial cancer: a National Cancer Database analysis
|
Davidson, Sarah J. |
|
|
57 |
S1 |
p. |
artikel |
35 |
Abstract #45: Mucinous ovarian neoplasm - Outcomes of a rare tumor
|
Hamedi, Bahareh |
|
|
57 |
S1 |
p. |
artikel |
36 |
Abstract #63: Non-cancer related emergency department utilization in newly diagnosed endometrial cancer patients
|
Liu, Chrissy |
|
|
57 |
S1 |
p. |
artikel |
37 |
Abstract #59: Non-serous fallopian tube carcinoma: a case series
|
Wang, Joyce Y. |
|
|
57 |
S1 |
p. |
artikel |
38 |
Abstract #16: Novel approaches to managing placenta accreta spectrum: is there an advantage to a longer delay in hysterectomy timing?
|
Haney, Karen |
|
|
57 |
S1 |
p. |
artikel |
39 |
Abstract #14: Older cervical cancer patients are inadequately screened prior to diagnosis: an opportunity for improvement
|
Kiff, Jaime M. |
|
|
57 |
S1 |
p. |
artikel |
40 |
Abstract #57: Outpatient specialty palliative care referral patterns among gynecologic cancer patients
|
Ratnaparkhi, Rubina |
|
|
57 |
S1 |
p. |
artikel |
41 |
Abstract #40: Palliative care referral and utilization at time of diagnosis in patients with recurrent or advanced stage gynecologic cancers at a single institution
|
Hill, Breana L. |
|
|
57 |
S1 |
p. |
artikel |
42 |
Abstract #47: Pathologic staging discrepancies between stage I and II ovarian and tubal high grade serous carcinoma (HGSC) and impact on survival.
|
Sompel, Kayla M. |
|
|
57 |
S1 |
p. |
artikel |
43 |
Abstract #13: Patient characteristics associated with aggressive end of life care in California, 2008–2019
|
Harrison, Ross |
|
|
57 |
S1 |
p. |
artikel |
44 |
Abstract #17: Peri-Operative Outcomes after Gravid Radical Hysterectomy for Treatment of Early-Stage Cervical Cancer
|
Makepeace, Lydia M. |
|
|
57 |
S1 |
p. |
artikel |
45 |
Abstract #43: Predicting final pathologic diagnosis by cervical excision margins and endocervical curettage
|
Woodson, Ryan |
|
|
57 |
S1 |
p. |
artikel |
46 |
Abstract #10: Predictors of HPV Vaccination in the Postpartum Period for Individuals Aged 18–26
|
Nguyen, Christine |
|
|
57 |
S1 |
p. |
artikel |
47 |
Abstract #60: Provider Acceptability of a Biopsy-First Approach to Diagnosis of Endometrial Cancer
|
Gross, Maya |
|
|
57 |
S1 |
p. |
artikel |
48 |
Abstract #56: Rate of homologous recombination repair gene expression in endometrial cancer patients
|
Smick, Alexandra |
|
|
57 |
S1 |
p. |
artikel |
49 |
Abstract #6: RBN-2397, a PARP7 Inhibitor, Synergizes with Paclitaxel to Inhibit Proliferation and Migration of Ovarian Cancer Cells
|
Aljardalia, Marwa W. |
|
|
57 |
S1 |
p. |
artikel |
50 |
Abstract #27: Readability assessment of Spanish online patient education materials in gynecologic oncology
|
Thomas, Dionna |
|
|
57 |
S1 |
p. |
artikel |
51 |
Abstract #42: Real-world outcomes of neoadjuvant chemotherapy for ovarian cancer: What happens to patients who never undergo surgery?
|
Bruce, Kelly |
|
|
57 |
S1 |
p. |
artikel |
52 |
Abstract #19: Serum Exosomal E6 and E7 Transcripts in HPV-Positive Cervical Cancer: Potential Biomarkers for Monitoring Disease Progression and Treatment Response
|
Roberts, Jill Nt |
|
|
57 |
S1 |
p. |
artikel |
53 |
Abstract #49: Simplification of Molecular Diagnostics for Point-of-Care HPV Screening
|
Roberts, Jill Nt. |
|
|
57 |
S1 |
p. |
artikel |
54 |
Abstract #50: Sociodemographic Factors Associated with Distress among a Diverse Gynecologic Oncology Patient Population
|
Cervantes, Jorge |
|
|
57 |
S1 |
p. |
artikel |
55 |
Abstract #34: Spatial RNA sequencing supports programmed death ligand 2 (PD-L2) as a potential immunotherapy target in high grade serous ovarian carcinoma (HGSOC)
|
Yates, Elise |
|
|
57 |
S1 |
p. |
artikel |
56 |
Abstract #37: Surgical complications with and without removal of the uterus during proctectomy following pelvic radiation for colorectal malignancy
|
Ray, Roshni |
|
|
57 |
S1 |
p. |
artikel |
57 |
Abstract #48: Survival in HPV and non-HPV associated invasive cervical cancer: outcomes in a large, integrated healthcare system
|
Williams, Gracie |
|
|
57 |
S1 |
p. |
artikel |
58 |
Abstract #33: The Clinical Course of Atypical Polypoid Adenomyoma: A Rare Lesion of Ovulatory Dysfunction
|
Lang, Susan |
|
|
57 |
S1 |
p. |
artikel |
59 |
Abstract #51: The relationship between history of sexual assault and cervical cancer: A meta-analysis
|
Hunsberger, Kyra |
|
|
57 |
S1 |
p. |
artikel |
60 |
Abstract #39: The Utility of a Gastrointestinal Workup in Patients Diagnosed with Borderline and Invasive Ovarian Mucinous Neoplasms
|
Tostrud, Lauren |
|
|
57 |
S1 |
p. |
artikel |
61 |
Abstract #18: Timely treatment in locally advanced cervical cancer is influenced by social vulnerability index and insurance type
|
Liang, Jessica |
|
|
57 |
S1 |
p. |
artikel |
62 |
Abstract #53: Tumor size predicts overall survival in uterine carcinosarcoma
|
Beer, Hannah M. |
|
|
57 |
S1 |
p. |
artikel |
63 |
Abstract #23: Understanding the patient experience on and after mirvetuximab soravtansine in platinum-resistant ovarian cancer
|
Smick, Alexandra |
|
|
57 |
S1 |
p. |
artikel |
64 |
Abstract #31: Understanding the Role Of At-Risk Cytology And Co-Testing Categories In Cervical Cancer Development: Are Current Tactics In Management Sufficient?
|
Doyle, Caroline K. |
|
|
57 |
S1 |
p. |
artikel |
65 |
Author Index
|
|
|
|
57 |
S1 |
p. |
artikel |
66 |
Editorial Board
|
|
|
|
57 |
S1 |
p. |
artikel |
67 |
Table of Content
|
|
|
|
57 |
S1 |
p. |
artikel |